Squarepoint’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,975
| Closed | -$31.6K | – | 4600 |
|
|
2023
Q4 | $31.6K | Buy |
+2,975
| New | +$35.8K | ﹤0.01% | 3889 |
|
|
2023
Q2 | – | Sell |
-711
| Closed | -$67.2K | – | 4007 |
|
|
2023
Q1 | $67.2K | Buy |
711
+634
| +823% | +$60.4K | ﹤0.01% | 3026 |
|
|
2022
Q4 | $7.47K | Buy |
+77
| New | +$11.2K | ﹤0.01% | 3123 |
|
|
2022
Q1 | – | Sell |
-879
| Closed | -$144K | – | 3504 |
|
|
2021
Q4 | $144K | Sell |
879
-486
| -36% | -$107K | ﹤0.01% | 2828 |
|
|
2021
Q3 | $373K | Sell |
1,365
-53
| -4% | -$16.2K | ﹤0.01% | 2139 |
|
|
2021
Q2 | $562K | Buy |
1,418
+178
| +14% | +$83.1K | ﹤0.01% | 2040 |
|
|
2021
Q1 | $669K | Buy |
1,240
+1,146
| +1,219% | +$713K | ﹤0.01% | 1811 |
|
|
2020
Q4 | $36K | Sell |
94
-281
| -75% | -$112K | ﹤0.01% | 2823 |
|
|
2020
Q3 | $142K | Sell |
375
-391
| -51% | -$173K | ﹤0.01% | 2210 |
|
|
2020
Q2 | $377K | Buy |
+766
| New | +$342K | 0.01% | 1466 |
|
|
2020
Q1 | – | Sell |
-885
| Closed | -$626K | – | 2495 |
|
|
2019
Q4 | $626K | Buy |
885
+724
| +450% | +$498K | ﹤0.01% | 1629 |
|
|
2019
Q3 | $103K | Buy |
+161
| New | +$128K | ﹤0.01% | 2186 |
|
|
2019
Q1 | – | Sell |
-220
| Closed | -$62K | – | 2432 |
|
|
2018
Q4 | $62K | Buy |
+220
| New | +$87K | ﹤0.01% | 1836 |
|
|
2018
Q3 | – | Sell |
-291
| Closed | -$132K | – | 2217 |
|
|
2018
Q2 | $132K | Buy |
291
+127
| +77% | +$80.5K | ﹤0.01% | 1615 |
|
|
2018
Q1 | $97K | Buy |
+164
| New | +$102K | ﹤0.01% | 1575 |
|
|
2017
Q3 | – | Sell |
-385
| Closed | -$359K | – | 1871 |
|
|
2017
Q2 | $359K | Buy |
+385
| New | +$377K | 0.01% | 1072 |
|
|
2017
Q1 | – | Sell |
-408
| Closed | -$327K | – | 1891 |
|
|
2016
Q4 | $327K | Buy |
+408
| New | +$368K | 0.01% | 1102 |
|
|
2016
Q3 | – | Sell |
-125
| Closed | -$103K | – | 1250 |
|
|
2016
Q2 | $103K | Sell |
125
-368
| -75% | -$401K | 0.01% | 975 |
|
|
2016
Q1 | $549K | Sell |
493
-14
| -3% | -$14.3K | 0.04% | 579 |
|
|
2015
Q4 | $632K | Buy |
+507
| New | +$839K | 0.07% | 426 |
|
|
2015
Q2 | – | Sell |
-207
| Closed | -$334K | – | 599 |
|
|
2015
Q1 | $334K | Buy |
+207
| New | +$307K | 0.12% | 269 |
|
Other funds holding TCRT
MP
CB
ACM
Squarepoint's TCRT Position: Q1 2024 in Review
Squarepoint sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 2,975 shares — an estimated $31.6K sold.
Squarepoint first reported a position in TCRT in Q1 2015 and held it in 21 quarters. The position peaked at $669K in Q1 2021. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.
- Squarepoint reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
- Squarepoint sold 2,975 Alaunos Therapeutics shares in Q1 2024, an estimated $31.6K.
- Squarepoint first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 21 quarters.
- Squarepoint's Alaunos Therapeutics position peaked at $669K in Q1 2021.
- 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.